Mouse model of PRSS1 p.R122H-related hereditary pancreatitis highlights context-dependent effect of autolysis-site mutation
Pancreatology · 2023-03 · 23 (2) · 131-142
DOI: 10.1016/j.pan.2023.02.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pancreatology, 2023-03. Verfasst von Zsanett Jancsó und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California Los Angeles, Los Angeles, CA, 90095, USA. Hauptthemen laut MEDLINE: Chymotrypsin, Pancreatitis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIDDK, Missouri University of Science and Technology.
Abstract (Originalsprache)
Mutation p.R122H in human cationic trypsinogen (PRSS1) is the most frequently identified cause of hereditary pancreatitis. The mutation blocks protective degradation of trypsinogen by chymotrypsin C (CTRC), which involves an obligatory trypsin-mediated cleavage at Arg122. Previously, we found that C57BL/6N mice are naturally deficient in CTRC, and trypsinogen degradation is catalyzed by chymotrypsin B1 (CTRB1). Here, we used biochemical experiments to demonstrate that the cognate p.R123H mutation in mouse cationic trypsinogen (isoform T7) only partially prevented CTRB1-mediated degradation. We generated a novel C57BL/6N mouse strain harboring the p.R123H mutation in the native T7 trypsinogen locus. T7R123H mice developed no spontaneous pancreatitis, and severity parameters of cerulein-induced pancreatitis trended only slightly higher than those of C57BL/6N mice. However, when treated with cerulein for 2 days, more edema and higher trypsin activity was seen in the pancreas of T7R123H mice compared to C57BL/6N controls. Furthermore, about 40% of T7R123H mice progressed to atrophic pancreatitis in 3 days, whereas C57BL/6N animals showed full histological recovery. Taken together, the observations indicate that mutation p.R123H inefficiently blocks chymotrypsin-mediated degradation of mouse cationic trypsinogen, and modestly increases cerulein-induced intrapancreatic trypsin activity and pancreatitis severity. The findings support the notion that the pathogenic effect of the PRSS1 p.R122H mutation in hereditary pancreatitis is dependent on its ability to defuse chymotrypsin-dependent defenses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, University of California Los Angeles, Los Angeles, CA, 90095, USA.
- Department of Surgery, University of California Los Angeles, Los Angeles, CA, 90095, USA. Electronic address: msahintoth@mednet.ucla.edu.
Förderung
- NIDDK NIH HHS
- NIDDK
- Missouri University of Science and Technology
- National Institutes of Health
- U.S. Department of Defense
Zitieren
APA
Jancsó, Z., Morales Granda, N. C., Demcsák, A., & Sahin-Tóth, M. (2023). Mouse model of PRSS1 p.R122H-related hereditary pancreatitis highlights context-dependent effect of autolysis-site mutation. Pancreatology, 23(2), 131-142. https://doi.org/10.1016/j.pan.2023.02.003
Vancouver
Jancsó Z, Morales Granda NC, Demcsák A, Sahin-Tóth M. Mouse model of PRSS1 p.R122H-related hereditary pancreatitis highlights context-dependent effect of autolysis-site mutation. Pancreatology. 2023;23(2):131-142. doi:10.1016/j.pan.2023.02.003
BibTeX
@article{Jancs2023,
author = {Jancsó, Zsanett and Morales Granda, Nataly C and Demcsák, Alexandra and Sahin-Tóth, Miklós},
title = {Mouse model of PRSS1 p.R122H-related hereditary pancreatitis highlights context-dependent effect of autolysis-site mutation},
journal = {Pancreatology},
year = {2023},
volume = {23},
number = {2},
pages = {131--142},
doi = {10.1016/j.pan.2023.02.003}
}
EUVIMED